Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2016

View Archived Issues

Novel S1P1 and S1P5 selective agonists identified for the treatment of autoimmune disease

Suven presents potent and selective H3R ligands with cognition-enhancing potential

DUOC-01 cells accelerate brain remyelination in vivo

Basilea Pharmaceutica patents MAPK inhibitors

F. Hoffmann-La Roche discloses HBsAg inhibitors

Chiesi develops compounds with mAChR antagonistic and beta2-adrenoceptor agonist activity

Merck Patent describes IRAK inhibitors

AbbVie reports SUV420H1 inhibitors

Early AR-101 immunotherapy is safe and effective in peanut-allergic preschool children

Researchers aim to find therapies for patients with hard-to-treat lymphomas

FDA gives favorable feedback to Corium's pre-IND application for Corplex memantine

FDA grants orphan drug designation to TG Therapeutics' TGR-1202

Ardelyx identifies promising gut-restricted TGR5 agonists

Insys Therapeutics reports positive results in phase III trial of buprenorphine sublingual spray

Abcellera Biologics completes antibody discovery partnership with Kodiak Sciences

Amgen receives FDA complete response letter for Parsabiv

Nymox Pharmaceutical announces positive results on fexapotide phase III trial

Mallinckrodt to sell its nuclear imaging business to IBA Molecular

Biothera expands collaboration with Merck & Co. for Keytruda combination study

FDA grants orphan drug designation to Scynexis' SCY-078 antifungal agent

FDA grants orphan drug designation to SFX-01 for the treatment of subarachnoid haemorrhage

Immix Biopharma completes stability testing for Imx-110

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...